Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 7,550.00
-850.00 (-10.12%)
At close: Feb 6, 2026
174.55% (1Y)
| Market Cap | 262.77B +181.3% |
| Revenue (ttm) | 25.95B +7.7% |
| Net Income | -27.82B |
| EPS | -693.34 |
| Shares Out | 34.80M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 657,114 |
| Average Volume | 1,102,045 |
| Open | 8,200.00 |
| Previous Close | 8,400.00 |
| Day's Range | 7,350.00 - 8,200.00 |
| 52-Week Range | 2,170.00 - 10,180.00 |
| Beta | 1.06 |
| RSI | 47.22 |
| Earnings Date | Nov 14, 2025 |